PortfoliosLab logoPortfoliosLab logo
Arcellx Inc (ACLX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US03940C1009
IPO Date
Feb 4, 2022

Highlights

EPS (TTM)
-$3.86
Total Revenue (TTM)
$35.90M
Gross Profit (TTM)
$810.00K
EBITDA (TTM)
-$209.52M
Year Range
$47.86 - $114.91
Target Price
$110.42
ROA (TTM)
-49.25%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Arcellx Inc

Often compared with ACLX:
ACLX vs. OLMAACLX vs. NVDA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Arcellx Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Arcellx Inc (ACLX) has returned 76.10% so far this year and 75.03% over the past 12 months.


Arcellx Inc

1D
0.04%
1M
0.91%
YTD
76.10%
6M
39.85%
1Y
75.03%
3Y*
55.04%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 4, 2022, ACLX's average daily return is +0.28%, while the average monthly return is +5.65%. At this rate, your investment would double in approximately 1.1 years.

Historically, 68% of months were positive and 32% were negative. The best month was Feb 2026 with a return of +66.6%, while the worst month was Jun 2023 at -28.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.

On a daily basis, ACLX closed higher 50% of trading days. The best single day was Feb 23, 2026 with a return of +77.4%, while the worst single day was May 6, 2025 at -18.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.77%66.58%0.91%76.10%
2025-11.16%-4.86%1.20%-0.99%-4.45%6.11%8.41%-2.80%18.32%9.93%-19.43%-10.33%-14.98%
202411.42%6.44%5.67%-28.08%3.96%6.13%11.99%11.21%21.49%0.91%4.51%-12.92%38.18%
20237.84%-16.16%10.00%38.53%3.44%-28.38%8.32%4.64%0.11%-1.76%49.02%5.65%79.15%
202213.93%-26.75%-22.04%10.80%49.30%14.66%-13.31%4.45%25.09%-15.08%55.37%84.40%

Benchmark Metrics

Arcellx Inc has an annualized alpha of 85.30%, beta of 0.88, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since February 07, 2022.

  • This stock captured 150.59% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -71.99%) — a profile typical of hedging or uncorrelated assets.
  • R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
85.30%
Beta
0.88
0.04
Upside Capture
150.59%
Downside Capture
-71.99%

Return for Risk

Risk / Return Rank

ACLX ranks 79 for risk / return — better than 79% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


ACLX Risk / Return Rank: 7979
Overall Rank
ACLX Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
ACLX Sortino Ratio Rank: 8585
Sortino Ratio Rank
ACLX Omega Ratio Rank: 8888
Omega Ratio Rank
ACLX Calmar Ratio Rank: 7878
Calmar Ratio Rank
ACLX Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Arcellx Inc (ACLX) and compare them to a chosen benchmark (S&P 500 Index).


ACLXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.83

0.90

-0.07

Sortino ratio

Return per unit of downside risk

2.47

1.39

+1.08

Omega ratio

Gain probability vs. loss probability

1.37

1.21

+0.16

Calmar ratio

Return relative to maximum drawdown

2.09

1.40

+0.69

Martin ratio

Return relative to average drawdown

4.96

6.61

-1.64

Explore ACLX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Arcellx Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Arcellx Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Arcellx Inc was 62.33%, occurring on May 18, 2022. Recovery took 14 trading sessions.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.33%Mar 1, 202256May 18, 202214Jun 8, 202270
-50.44%Nov 12, 2024119May 6, 2025200Feb 23, 2026319
-38.52%Jun 13, 20224Jun 16, 2022122Dec 9, 2022126
-33.53%May 11, 202334Jun 29, 202391Nov 7, 2023125
-32.32%Mar 21, 202436May 10, 202482Sep 9, 2024118

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Arcellx Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Arcellx Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ACLX relative to other companies in the Biotechnology industry. Currently, ACLX has a P/S ratio of 180.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items